Women in Innovation Programme was launched in 2016 by @innovateuk with the overall aim of increasing gender equality in business-led innovation. The annual competition supports and celebrates remarkable #women entrepreneurs & senior business leaders @KTNUK
iuk.ktn-uk.org/programme/wome…
#WomenInInnovation
Katerina Spranger-@OxfordHeartbeat
Claire Trant-Untap
@lornuccia-Phyona
Monika Tomecka-@uFraction8
@LydiaMapstone-@BoobyBiome
Louise Ben-Nathan-@LBNInnovations
Divia Bhatnagar-Medical Intelligence Group
@JoBarrow-Curb Health
@KTNUK #SDG5
iuk.ktn-uk.org/programme/wome…
Women In Innovation
Oriane Chausiaux-Heartfelt Technologies
Samantha Payne-@openbionics
Kate Allan-@ExpHandUK
Fatemeh Ameri-PreciousMD
Susan Kelly @justdrmum-@afloanalytics
@BeckyCotton-@hello_lumino
Miriam Silver @ClinPsy-BERRI
Michelle Connor-@KinvaApp

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Krzysztof Potempa

Krzysztof Potempa Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @BRAINCURES

Mar 14
Can you imagine applying biological intelligence-BI to achieve a 3 to 5-fold increase on AstraZeneca’s reported 19% success rate in the proportion of pipeline molecules that advance from preclinical investigation to completion of Phase III clinical trials?
bioindustry.org/news-listing/m…
@BraincuresLTD's biological intelligence (BI) approach eliminated 59 of 72 target-compound pairs associated with Phase III clinical failures to enable 60 to 100% likelihood of clinical success rates across compounds that target 13 different protein classes
bioindustry.org/news-listing/m…
While there are nearly 400 companies that apply artificial intelligence (AI) to de-risk certain parts of the drug development cycle, @BraincuresLTD are the only company actively using the notion of biological intelligence (BI) in research and development
bioindustry.org/news-listing/m…
Read 9 tweets
Mar 13
🧵@KqLabs is a major initiative, delivered by @TheCrick supported by funding from @innovateuk, and with collaboration from the @KQ_London @HDR_UK @GenomicsEngland, which aims to bring together a powerful eco-system in support of data-driven health startups
knowledgequarter.london/kq-labs/ Image
Providing critical support to early stage data-driven health science startups, @KqLabs offers a customised framework with a 16-week accelerator programme. The program also includes workshops to inspire and nurture the next generation of start-ups
@TheCrick
crick.ac.uk/news/2018-09-1…
Veronique Birault, Head of Translation at the Francis Crick Institute, said: “This is the start of a very exciting journey for the ten start-ups, and also a great contribution towards building the ecosystem for data-driven health in the Kings Cross area”
crick.ac.uk/news/2018-10-2…
Read 16 tweets
Mar 13
🧵 @miramurati is a name that is gaining recognition in the world of artificial intelligence (AI). She is the brain behind the development of @OpenAI's ChatGPT, an #AI language model that has revolutionized the way we interact with machines @GlobalWomanCo
globalwomanmagazine.com/mira-murati-th…
ChatGPT is essentially a large conversational model—a big neural net that’s been trained to predict the next word—and the challenges with it are similar challenges we see with the base large language models: it may make up facts
@miramurati CTO @OpenAI #AI
time.com/6252404/mira-m…
While @sama has a flair for generating headlines by alluding to science fiction horror stories with AGI villains, @miramurati characterizes consciousness as a philosophical idea, rather than a scientific one (“It’s a bit of a different vector,” she says)
fastcompany.com/90855799/6-thi…
Read 7 tweets
Mar 11
Greg Becker, the CEO of Silicon Valley Bank sold $3.57 million of stock at an average price of $287.42 in a sell-off two weeks before it collapsed. CFO Daniel Beck ditched $575,000. The price plunged to just $39.49 before the FDIC seized the bank's assets
dailymail.co.uk/news/article-1…
Federal Deposit Insurance Corporation @FDICgov, which typically protects deposits up to $250,000, said it had taken charge of the roughly $175bn (£145bn) in deposits held at the Silicon Valley Bank, the 16th largest in the US @shermannatalie @JamesClayton5
bbc.co.uk/news/business-…
SVB’s condition deteriorated so quickly that it couldn’t last just 5 more hours. That’s because its depositors were withdrawing their money so fast that the bank was insolvent, & an intraday closure was unavoidable due to a classic bank run @DennisKelleher
cnn.com/2023/03/11/bus…
Read 12 tweets
Dec 17, 2022
@KaterinaGalai, spoke to @SamBarrell1 about her career as an accomplished healthcare leader, including her leadership role at Europe’s largest single-site biomedical research organisation, the Francis Crick Institute @TheCrick, during the COVID-19 pandemic
cogconsortium.uk/women-in-cog-i…
Sam “only ever planned one thing…and that was to be a doctor. For me, it’s just about being open-minded, enjoying challenges and being able to overcome them.” @SamBarrell1 prioritises one factor when considering a position: “they have to be purpose-led.”
Sam recalls that the leadership team @TheCrick had a lightbulb moment-There was a realisation that scientists could be tested to see if they were SARS-CoV-2 positive. We really needed them in their labs–it wasn’t really going to work for them to be at home
cogconsortium.uk/women-in-cog-i…
Read 4 tweets
Dec 16, 2022
885 of all small molecule drugs pass the rule-of-five test; of these, 619 (70%) are actually dosed orally, whereas 159 (20%) of orally dosed drugs fail at least one of the rule-of-five parameters
-John P Overington, Bissan Al-Lazikani and Andrew L Hopkins
nature.com/articles/nrd21…
@johnpoverington et al determine that all current drugs with a known mode-of-action act through 324 distinct molecular drug targets. 266 are human-genome-derived proteins, and the remainder are bacterial, viral, fungal or other pathogenic organism targets
readcube.com/articles/10.10…
Small molecule drugs modulate 248 proteins, of which 207 are targets encoded by the human genome. Oral #smallmolecule drugs target 227 molecular targets, of which 186 are human
-@johnpoverington, Bissan Al-Lazikani, Andrew Hopkins
nature.com/articles/nrd21…
Read 14 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(